News | June 04, 2022
RH Capital announces investments to improve women’s health
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Auld is a seasoned Financial Executive with over 30 years of relevant experience
New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services
Subscribe To Our Newsletter & Stay Updated
